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Abstract
Background: Using a rat model we have found that the bioflavonoid silymarin (SY) ameliorates
some of the negative consequences of in utero exposure to ethanol (EtOH). In the current study
our aim was to determine if spatial working memory (SWM) was impaired in offspring whose
mothers were maintained on a liquid diet containing EtOH during different gestational weeks. We
also determined if SWM was altered with a concomitant administration of SY with EtOH during
specific gestational weeks.
Methods: We provided pregnant Fischer/344 rats with liquid diets containing 35% EtOH derived
calories (EDC) during specific weeks of the gestational period. A silymarin/phospholipid compound
containing 29.8% silybin co-administered with EtOH was also administered during specific weeks
of the gestational period. We tested SWM of the offspring with a radial arm maze on postnatal day
(PND) 60. After testing the rats were sacrificed and their brains perfused for later analysis.
Results: We observed SWM deficits, as well as a significantly lower brain weight in female offspring
born of mothers treated with EtOH during the third week of gestation in comparison to mothers
treated during either the first or second weeks of gestation. Rats from any group receiving EtOH
in co-administration with SY showed no significant deficits in SWM.
Conclusion: EtOH treatment during the last week of gestation had the greatest impact on SWM.
The addition of SY to the EtOH liquid diet appeared to ameliorate the EtOH-induced learning
deficits.
Background
Fetal alcohol syndrome (FAS) produces a variety of phys-
ical and neuropsychological disorders in humans and ani-
mals [1]. In humans, FAS children tend to have a lower
average IQ and also display a propensity for hyperactivity
[2]. In rats, exposure to ethanol (EtOH) during gestation
produces a cascade of neuroanatomical abnormalities. In
particular, EtOH treatment during the later part of gesta-
tion produces increased apoptosis in the hippocampus of
rats [3], which leads to subsequent neurobehavioral
deficits.
Olton and Papas [4], through testing on the radial arm
maze (RAM), found the hippocampus to be the primary
brain region involved in spatial working memory (SWM).
Prior to testing, the fimbria-fornix (the major input-out-
put source of the hippocampus) of rats was lesioned. Ref-
erence memory (memory for a response set that is the
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same on every trial) and working memory (memory that
included proactive interference and involves procedures
that require memory for events consistent in all trials)
were tested. Large lesions to the fimbria-fornix impaired
postoperative performance on the working memory task,
but no reference memory deficits were seen. Seizures pro-
duced in the CA1 area of the hippocampus are also shown
to produce deficits in working memory, but not in refer-
ence memory [5].
Exposure to EtOH during gestation has toxic effects on the
developing hippocampus. EtOH has been shown to dis-
rupt the development hippocampal mossy fibers when
administered during gestation [6]. Pyramidal cell loss also
occurs, particularly in the CA1 area of the hippocampus
when exposed during gestational days (GD) 10–21. Long-
term potentiation (LTP) is also disrupted in rats prenatally
exposed to EtOH [7]. Hippocampal slices from adult rats
exposed to EtOH during gestation show a decreased pro-
pensity toward LTP in area CA1 of the hippocampus in
comparison to pair-fed controls. Prenatal exposure to
EtOH in rats also significantly reduces the sensitivity of
area CA1 of the hippocampus to NMDA [8]. Rats exposed
to EtOH during gestation show an enhancement of the
Mg2+ block of the NMDA channel, further diminishing the
capacity for hippocampal LTP.
Linked to the physical evidence of EtOH-induced neu-
rodevelopmental abnormalities are the behavioral deficits
that reflect the damage to the brain areas critical to the
behavioral performance. Tests using the Morris Water
Maze (MWM; a test of spatial memory) have shown an
EtOH-induced impairment in spatial memory [9-12]. Rats
treated with EtOH during gestation take significantly
more time to reach the escape platform than do rats with-
out EtOH exposure. T-maze testing also shows an EtOH-
induced impairment to achieve the goal-arm in prenatally
exposed rats [13].
EtOH exposure during gestation also causes deficits in
SWM in pups tested on the RAM [14,15]. Rats exposed to
35% ethanol-derived calories (EDC) during gestation
show an impaired performance on the RAM. Those that
reached criterion needed significantly more trials to com-
plete testing and committed significantly more mistakes.
Rats treated with 17% EDC during gestation showed no
significant RAM deficiencies, demonstrating the dose-
dependent manner in which EtOH works.
Also relevant to the consequences of in utero exposure to
EtOH is the fact that particular areas of the brain are sexu-
ally dimorphic, which subserves sexually dimorphic
behavior. Spatial working memory is an example of sexu-
ally dimorphic behavior. Male rats are found to consist-
ently learn the RAM more rapidly than females [16].
Females also performed significantly worse than males on
the RAM following a treatment of 1.5 g/kg/day of EtOH
[17]. This impairment persisted even after treatment was
completed.
We have investigated the potential fetoprotective capacity
of silymarin (SY) against the toxic effects of in utero expo-
sure to EtOH. SY is a flavanoid that has shown antioxidant
properties. The mechanism through which SY protects the
fetus from EtOH toxicity is not fully understood, but pos-
sible mechanisms include neutralization of free radicals
by the bioflavanoids leading to decreased lipid perioxida-
tion; increased protein synthesis, thereby promoting
regenerating processes; stabilization of cell membranes;
and possible binding of SY to an estradiol binding site sit-
uated on a subunit of RNA polymerase I, which would
stimulate the synthesis of ribosomal RNAs, possibly
restoring structural proteins and damaged enzymes in the
cells nucleus [18-22]. SY has also been shown to cross the
placental barrier, and appears to protect the fetus from
weight loss produce by EtOH-exposure during gestation
[23].
Busby, LaGrange, Edwards, and King [24] found SY to
protect the fetus in utero from the toxic effects of EtOH.
Rats born to mothers treated with EtOH and SY showed
no significant differences in RAM performance in compar-
ison to a pair-fed group. Rats born to mothers treated with
only EtOH showed an impaired performance on the RAM
in comparison to a pair-fed control group. They also
found males to perform significantly better than females
between groups, as females took significantly more days
to reach criterion than males on the RAM.
Given that SY has been successful in preventing SWM def-
icits on the RAM (in the rat model) we again examined its
fetoprotective properties. We further tried to determine
which week of the rats' three-week gestational period was
the most critical in terms of EtOH-induced SWM deficits
(as measured by RAM performance).
Methods
Subjects
Subjects were 224 Fisher/344 rats (112 females, 111
males), the offspring of 58 female Fisher/344 rats that had
been assigned to experimental groups. The 58 female rats
received Purina lab rat chow and water ad libitum until
they reached pregnancy weight (130 g). The females were
housed with male rats until pregnancy was confirmed by
vaginal smear. Once pregnancy was confirmed, the rats
were placed in standard plastic laboratory maternity tubs
and assigned to one of fourteen gestational groups (Table
1). Group 1 (EtOH 1–7) received a liquid Bio-Serv diet
(Frenchtown, NJ) containing 35% ethanol-derived calo-
ries (EDC) during days 1–7 of the gestational period.BMC Complementary and Alternative Medicine 2004, 4 http://www.biomedcentral.com/1472-6882/4/4
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Group 2 (EtOH 8–14) received a liquid Bio-Serv diet con-
taining 35% EDC during days 8–14 of the gestational
period. Group 3 (EtOH 15–21) received a liquid Bio-Serv
diet containing 35% EDC during days 15–21 of the gesta-
tional period. Group 4 (EtOH/SY 1–7) received a Bio-Serv
diet containing 35% EDC along with 400-mg/kg sily-
marin during days 1–7 of the gestational period. Group 5
(EtOH/SY 8–14) received a liquid Bio-Serv diet contain-
ing 35% EDC along with 400-mg/kg silymarin during
days 8–14 of the gestational period. Group 6 (EtOH/SY
15–21) received a liquid Bio-Serv diet containing 35%
EDC along with 400-mg/kg silymarin during days 15–21
of the gestational period. Group 7 (LD/SY 1–7) received a
Bio-Serv diet containing an isocaloric quantity of dextrose
maltose that matched the caloric amount in the ethanol
diet along with 400-mg/kg silymarin during days 1–7 of
the gestational period. Group 8 (LD/SY 8–14) received a
Bio-Serv diet containing an isocaloric quantity of dextrose
maltose that matched the caloric amount in the ethanol
diet along with 400-mg/kg silymarin during days 8–14 of
the gestational period. Group 9 (LD/SY 15–21) received a
Bio-Serv diet containing an isocaloric quantity of dextrose
maltose that matched the caloric amount in the ethanol
diet along with 400-mg/kg silymarin during days 15–21
of the gestational period. The previous 9 groups received
a liquid Bio-Serv diet containing an isocaloric quantity of
dextrose maltose that matched the caloric amount in the
ethanol diet for any period of gestation in which a treat-
ment was not specified.
Group 10 (EtOH Full) received a liquid Bio-serv diet con-
taining 35% EDC throughout the gestational period.
Group 11 (EtOH/SY Full) received a liquid Bio-Serv diet
containing 35% EDC along with 400-mg/kg silymarin
throughout the gestational period. Group 12 (LD/SY Full)
received a liquid Bio-Serv diet containing an isocaloric
quantity of dextrose maltose that matched the caloric
amount in the ethanol diet along with 400-mg/kg sily-
marin throughout the gestational period. Group 13 (LD
Full/Pair-Fed) received a liquid Bio-Serv diet containing
an isocaloric quantity of dextrose maltose that matched
the caloric amount in the ethanol diet restricted to the
consumption rate per week of Etoh 1–7 for week 1, Etoh
8–14 for week 2, and Etoh 15–21 for week 3. Group 14
(Chow) received chow and water ad libitum throughout
the gestational period. All pups were kept with birth
mothers until weaning. Daily intake of liquid diet across
mothers was 68 ml ± 5 ml/day.
Once pups reached 21 days of age they were weaned and
placed in an individual standard laboratory cage. On the
day of weaning 8 males and 8 females from each group
were randomly selected for subsequent RAM testing. A
total of 16 pups were taken from each group.
Apparatus and procedures
Testing Apparatus for Spatial Working Memory
All testing took place on an 8-arm radial arm maze. The
central platform measured 35.56 cm in diameter, each
arm was 82.55 cm long and 10.16 cm wide, and the plat-
form was mounted on 53.34 cm legs. The apparatus was
painted flat black. All test sessions were videotaped.
Spatial Working Memory Testing Procedure
The rats began SWM testing at 12 weeks. They were food-
deprived to 85% free-feeding body weight beginning two-
weeks prior to RAM testing. RAM testing consisted of 3
phases: habituation, training, and testing. Habituation
[postnatal day (PND) 58]: rats were placed individually in
the center of the maze and allowed to explore for 25
minutes. Training (PND 59): 7 arms of the maze were
blocked, allowing access to only one arm. Food rewards (a
Table 1: Experimental Group Treatment Per Week Over the Three-Week Gestation Period.
Group Name Treatment GD 1–7 (Week 1) Treatment GD 8–14 (Week 2) Treatment GD 15–21 (Week 3)
1 EtOH 1–7 EtOH LD LD
2 EtOH 8–14 LD EtOH LD
3 EtOH 15–21 LD LD EtOH
4 EtOH/SY 1–7 EtOH/SY LD LD
5 EtOH/SY 8–14 LD EtOH/SY LD
6 EtOH/SY 15–21 LD LD EtOH/SY
7 LD/SY 1–7 LD/SY LD LD
8 LD/SY 8–14 LD LD/SY LD
9 LD/SY 15–21 LD LD LD/SY
10 EtOH Full EtOH EtOH EtOH
11 EtOH/SY Full EtOH/SY EtOH/SY EtOH/SY
12 LD/SY Full LD/SY LD/SY LD/SY
13 LD Full LD LD LD
14 Chow Chow Chow ChowBMC Complementary and Alternative Medicine 2004, 4 http://www.biomedcentral.com/1472-6882/4/4
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small piece of red Froot Loop) were placed at short inter-
vals down the arm in order to entice the rat to the end of
the arm. Once the rat reached the end of the arm, the rat
was returned to the center platform and the arm was re-
baited in order to continue the training procedure. Near
the end of the 15-min phase, food rewards were only
placed at the end of the arm to train the rat to run to the
end of the arm to receive the reward. Testing (PND 60):
rats had 5 min to reach the end of all 8 arms (criterion).
The end of each arm was baited with a food reward.
Reaching criterion was not contingent upon consumption
of the bait. Each rat was allowed 8, 5-min sessions to reach
criterion. Mistakes were also recorded and defined as full
exit of an arm to the central platform after the food reward
was consumed followed by subsequent re-entry to the
complete end of the arm in search of the previously con-
sumed reward anytime during the five minute testing
period. The RAM was washed with a 70% ethanol solu-
tion between each trial.
Perfusion
Two pups from each group were sacrificed on the day they
were born and their brains extracted for use in later pro-
tein analysis (data not presented here). On PND 90, all
rats were sacrificed and their brains extracted. Rats were
injected with 1 cc of euthasol and placed back into their
home cage. When the rats did not respond to tactile stim-
ulation, they were taken to the perfusion tray. A cut was
made from the sternum to the neck and the ribs were
pulled away exposing the still-beating heart. A perfusion
needle containing 30 ml Ringers solution was adminis-
tered intracardially, followed by 30 ml of fixing solution.
The brains were then extracted, weighed, and preserved in
formalin for later analysis (data not presented here).
Statistics
A priori contrasts were conducted to determine if there
were significant differences between groups on all
dependent measures (RAM, mistakes, birth weight, wean-
ing weight, RAM testing weight, perfusion weight, and
total brain weight). SPSS Reliability Analysis was used for
inter-rater reliability.
Results
An independent groups t-test was conducted in order to
assess gender differences in performance on the RAM. This
test revealed a significant difference between males (M =
3.84) and females (M = 4.62), t(221) = 2.38, p = .01. These
results provided the rationale for analyzing male and
female data separately.
A priori contrasts were conducted to assess group differ-
ences on the RAM for females. The EtOH 15–21 group (M
= 6.75) took longer to complete RAM testing than the
EtOH 1–7 group (M = 3.88), t(98) = 2.26, p = .02 as well
as the EtOH 8–14 group (M = 4.13), t(98) = 2.07, p = .04
(Table 2). The contrasts also revealed the EtOH/SY full
group (M = 2.50) took less time to complete RAM testing
than the EtOH full group (M = 6.13), t(98) = 2.85, p =
.005 as well as the LD full group (M = 5.13), t(98) = 2.08,
p = .04 (Table 3). A priori contrasts were also conducted to
assess group differences on mistakes made by the females.
The EtOH full group (M = 19.25) committed more mis-
takes than theLD full group (M = 9.38), t(98) = 2.08, p =
.04 as well as the EtOH/SY full group (M = 10.25), t(98) =
2.08, p = .04 (Table 3). The results of a reliability analysis
indicated a 98% agreement among the raters who
recorded the mistakes.
No significant differences were found in RAM testing for
the males. A priori contrasts were conducted in order to
assess group differences on mistakes made by the males.
The EtOH 1–7 group (M = 7.88) committed less mistakes
than the EtOH 15–21 group (M = 18.75), t(94) = 2.57, p
= .01. No other significant differences were found. The
results of a reliability analysis indicated a 98% agreement
among the raters who recorded the mistakes.
A priori contrasts were also conducted to assess female
group differences in weight as recorded at birth, weaning,
on the first day of RAM testing, and at the time of brain
perfusion. The contrasts revealed the EtOH 15–21 group
(M = 5.14) weighed more at birth than the EtOH 1–7
group (M = 4.65), t(98) = 2.81, p = .006 as well as EtOH
8–14 group (M  = 4.76), t(98) = 2.18, p = .03 (Table 4). At
Table 2: Female Data on RAM Performance and Mistakes for EtOH weekly treatment groups.
RAM (days) Mistakes
MS D MS D
EtOH 1–7 3.88 2.23 15.13 10.93
EtOH 8–14 4.13 2.59 17.25 8.41
EtOH 15–21 6.75* 2.43 13.75 7.17
*p < 0.05BMC Complementary and Alternative Medicine 2004, 4 http://www.biomedcentral.com/1472-6882/4/4
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weaning, this trend had reversed, revealing the EtOH 15–
21 group (M = 25.74) to weigh less than the EtOH 1–7
group (M = 29.88), t(98) = 2.00,p = .04 as well as the
EtOH 8–14 group (M = 30.84), t(98) = 2.45, p = .02. This
trend continued at perfusion, with the EtOH 15–21 group
(M = 139.79) weighing less than the EtOH 1–7 group (M
= 154.21), t(98) = 2.42, p = .02 as well as the EtOH 8–14
group (M = 157.87), t(98) = 3.03, p = .003. There was also
a significant difference in total brain weight (TBW) as the
EtOH 15–21 group (M  = 1.57) weighed less than the
EtOH 1–7 group (M = 1.63), t(96) = 2.42, p = .02 as well
as the EtOH 8–14 group (M = 1.64), t(96) = 3.06, p = .003.
Additional contrasts on the female weight data revealed
significant differences in birth weight as the EtOH full
group (M = 5.13) weighed more than the LD full group
(M = 4.54), t(98) = 3.38, p = .03; RAM testing weight as the
EtOH full group (M = 100.14) weighed more than the
EtOH/SY full group (M = 90.56), t(98) = 2.15,p = .03; and
perfusion weight as the EtOH full group (M = 168.24)
weighed more than the EtOH/SY full group (M = 148.75),
t(98) = 3.27, p  = .002. Further weight differences are
shown in Table 5.
A priori contrasts were also conducted to assess group dif-
ferences in the weight data obtained from males at birth,
weaning, on the first day of RAM testing, and at the time
of brain perfusion. The contrasts revealed significant dif-
ferences in birth weights as the EtOH 1–7 group (M =
4.65) weighed less than the EtOH 15–21 group (M  =
5.29), t(94) = 2.71, p = .003 (Table 6); the EtOH/SY 1–7
group (M = 3.97) weighing less than the EtOH/SY 15–21
group (M = 4.80), t(94) = 3.53, p = .001; the LD full group
(M = 4.51) weighing less than the EtOH full group (M =
Table 3: Female Data for RAM Performance and Mistakes for selected full treatment groups.
RAM (days) Mistakes
MS D MS D
EtOH/SY full 2.50 1.77 10.25 6.48
EtOH full 6.13* 3.40 19.25* 12.35
LD full 5.13 2.48 9.38 7.03
*p < 0.05
Table 4: Female Weight Data for EtOH weekly treatment groups.
Birth (g) Weaning (g) RAM (g) Perfusion (g) TBW (g)
MS D MS D MS D MS D MS D
EtOH 1–7 4.65 0.14 29.88 2.80 88.86 10.72 154.22 13.94 1.63 0.05
EtOH 8–14 4.76 0.44 30.84 3.80 92.38 8.27 157.87 8.65 1.64 0.03
EtOH 15–21 5.14* 0.32 25.74* 4.78 86.49* 14.49 139.79* 19.89 1.57* 0.10
*p < 0.05
Table 5: Female Weight Data for selected EtOH/SY and LD/SY weekly treatment groups.
Birth (g) Weaning (g) RAM (g) Perfusion (g)
M S DM S DM S DM S D
EtOH/SY 1–7 4.11 0.57 26.06 3.36 85.65 7.59 149.18 6.56
LD/SY 1–7 4.49* 0.40 25.63 3.76 92.54 9.28 140.30 12.47
EtOH/SY 8–14 4.75 0.38 27.25 6.74 82.19 10.61 155.34 7.35
LD/SY 8–14 5.12* 0.14 31.44* 5.78 94.36* 4.96 151.28 9.00
*p < 0.05BMC Complementary and Alternative Medicine 2004, 4 http://www.biomedcentral.com/1472-6882/4/4
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5.17), t(94) = 2.71, p = .008; and the LD full group weigh-
ing less than the EtOH/SY full group (M = 5.43), t(94) =
3.76, p = .000 (Table 6). Contrasts further revealed a sig-
nificant difference in weaning weight as the EtOH 15–21
group (M  = 30.83) weighed less than the EtOH 8–14
group (M = 35.32), t(94) = 2.00, p = .04.
Discussion
The results of this study demonstrate that EtOH exposure
during gestation affects subsequent performance on the
RAM in EtOH-exposed adult rats. Further, SWM deficits
were found to be more severe in female EtOH treated rats
than in male EtOH treated rats, as reported earlier [16,17].
The fetoprotective effects of SY were also replicated.
Female pups born to the EtOH 15–21 group showed sig-
nificant RAM deficits in comparison to the EtOH 1–7 and
EtOH 8–14 groups, indicating that, in females at least, the
hippocampus appears to be more sensitive to EtOH expo-
sure during the last week of gestation. Of interest is that
males did not show this difference, although the EtOH
15–21 group did commit significantly more mistakes
than did the EtOH 1–7 group. This may indicate that
EtOH exposure later in the gestational period may have
caused more hippocampal disruption in males as well as
females; although this difference may be due EtOH-
induced hyperactivity. Gender differences in response to
in utero exposure to EtOH were evident in SWM capacity.
Male rats consistently learned the RAM task quicker than
female rats [16]. Females also seem to be more sensitive to
the detrimental effects of EtOH as measured by RAM per-
formance [17].
Consistent with the Busby, LaGrange, Edwards, and King
[24] investigation, those rats treated with EtOH in combi-
nation with SY did not differ significantly in RAM testing
or mistakes made when compared to the pair-fed group.
The female rats born to the EtOH full group took signifi-
cantly longer to complete RAM testing than did the EtOH/
SY full group, and also committed more mistakes than did
the EtOH/SY full group. Interestingly, the LD full group
took significantly more days to complete RAM testing
than did the EtOH/SY full group. This may have been the
result of residual hyperactivity, as in utero exposure to
EtOH can cause subsequent hyperactivity in the juvenile
rat [14].
Birth weight analysis (group weight mean) for females
showed that initially, the EtOH 15–21 group weighed sig-
nificantly more than did either the EtOH 1–7 or the EtOH
8–14 group, but at weaning this trend had reversed. Both
the EtOH 1–7 group and the EtOH 8–14 group weighed
significantly more than did the EtOH 15–21 group.
Although no significant differences were found at RAM
testing weight, the EtOH 1–7 group and the EtOH 8–14
group weighed significantly more that the EtOH 15–21
group at the time of brain perfusion. The same two groups
also had larger total brain weights than did the EtOH 15–
21 group. In relation to the differences found on RAM
testing, these lower total brain weights could be related to
the cellular/structural loss seen from the exposure of
EtOH to a fetus in utero [25,26] and may provide the
physiological underlying causes of the deficiencies found
in RAM testing.
Female pups exposed to EtOH in co-administration with
SY did not display SWM deficits on the RAM. Further, no
deficits on RAM performance were found in any of the
groups treated with SY. The mechanism through which SY
protects the fetus from EtOH toxicity is not fully under-
stood. SY may work by neutralizing free radicals and
decreasing lipid peroxidation [19], increasing protein syn-
thesis [20,27,28], thereby promoting regenerative proc-
esses, as well as possible competitive binding to an
estradiol binding site situated on a subunit of RNA
polymerase I [22,23,18], which would stimulate the syn-
thesis of ribosomal RNAs, possibly restoring structural
proteins and damaged enzymes in the cells nucleus. If SY
binds to the estradiol site during gestation, the ameliora-
tive effects of SY might be due to the regenerative proper-
ties of this binding site.
During brain development, certain types of cells are pro-
grammed to move to precise locations in the brain (i.e.,
Table 6: Male Weight Data for EtOH weekly treatment groups.
Birth (g) Weaning (g) RAM (g) Perfusion (g)
MS D MS D MS D MS D
EtOH 1–7 4.65 0.14 32.15 1.26 117.51 10.05 221.46 15.00
EtOH 8–14 5.08 0.40 35.32* 6.73 109.47 32.03 234.51 20.12
EtOH 15–21 5.29* 0.32 30.83 2.85 116.74 16.44 224.72 12.91
*p < 0.05BMC Complementary and Alternative Medicine 2004, 4 http://www.biomedcentral.com/1472-6882/4/4
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the hippocampus) to serve a specific purpose. The pres-
ence of EtOH can cause interference with the molecules
promoting appropriate cell movement, disrupting the cor-
rect paths of these migrating cells, leading to incorrect cell
migration and adhesion. Silymarin, through its scaveng-
ing of the free radicals created by the oxidation of EtOH
[28] may prevent the disruption of these signals and allow
for correct migration. If this movement is altered by the
presence of EtOH, the incorrect migration of developing
cells can occur, reaching incorrect targets and causing
behavioral deficits [29].
Developing brain cells exposed to EtOH during gestation
show signs of hypoxia, having a reduced oxygen supply
that may lead to developmental delays and malforma-
tions. Hypoxia also causes the formation of free radicals,
the toxic by-products of oxygen metabolism. Free radicals
can damage the cell surface, causing swelling, cellular
damage, and possibly death to these cells. Silymarin acts
as an antioxidant by scavenging the free radicals that
induce lipid peroxidation, and also stimulates regenera-
tion through increased protein synthesis [18]. Rats
exposed to EtOH during gestation develop fewer neurons
and glial cells than control rats, including the cells located
in the hippocampus [30]. When fetuses are exposed to
ethanol during GD 10–21, pyramidal cell loss also occurs,
particularly in CA1 of the hippocampus [6]. Dendritic
spines, when exposed to ethanol prenatally, show
increased variability in relation to controls [31]. Given
that dendritic spines modulate the entry of information
through modifications in their density and shape, the var-
iation in spine development due to ethanol exposure
might contribute to the cognitive deficits associated with
FAS. Rats exposed to EtOH prenatally also develop fewer
purkinje cells than controls [32]. Purkinje cells receive
many excitatory inputs. The purkinje cells inhibit many of
these inputs, as purkinje cells are inhibitory by nature, to
allow for a clear communication of incoming information
from these cells with the rest of the brain. A loss in
purkinje cells can also result in behavioral deficits, as well
as lowered total brain volume and weight.
When EtOH is administered gestationally, an enhance-
ment in the Mg2+  block of the NMDA-receptors is
observed, which suggests that prenatal EtOH exposure
facilitates a more complex block of the NMDA channel by
Mg2+  [8]. NMDA-receptor activation is critical in the
induction of LTP [33]. LTP is one of the primary manifes-
tations of plasticity in the hippocampus and consists of
excitatory postsynaptic potentials that are sustained for at
least 30-minutes after tetanic stimulation [7,34]. Pups
prenatally exposed to EtOH would then have a dimin-
ished capacity for hippocampal LTP [7,34,33]. Lowering
the capacity for LTP would affect the pups' ability to create
and keep spatial maps in the hippocampus during RAM
testing. This would translate into the observed behavioral
deficits on the RAM. It might also account for more severe
deficits observed in the female rats receiving EtOH during
the last week of gestation (the critical developmental
period for the hippocampus) and female rats receiving
EtOH treatment throughout gestation.
Conclusion
Because female pups born to mothers treated with EtOH
during the last week of gestation showed the greatest SWM
deficits, it appears that hippocampal development is most
vulnerable to EtOH-induced toxicity during this gesta-
tional period. Further, SY was shown to protect the fetus
in utero from the toxic effects of EtOH. The treatment
groups that did not receive SY in co-administration with
EtOH were far less proficient on the RAM than were
EtOH/SY treatment groups. The fetoprotective properties
of SY are not yet fully understood, but due to our consist-
ent observations of protectivity, the properties of SY in co-
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